Literature DB >> 19854622

Executive function in schizophrenia: influence of substance use disorder history.

Roberto Rodriguez-Jimenez1, Alexandra Bagney, Isabel Martinez-Gras, Guillermo Ponce, Eva Maria Sanchez-Morla, Maria Aragües, Gabriel Rubio, Miguel Angel Jimenez-Arriero, Jose Luis Santos, Tomas Palomo.   

Abstract

Cognitive function in schizophrenia has been associated with different sociodemographic and clinical variables. Substance use disorder (SUD) history has also been associated with cognition in schizophrenia; however, contradictory results have been found regarding its influence on cognitive function. Our aim was to study the relationship between executive function and a) age, b) duration of illness, c) number of psychotic episodes, d) positive symptoms, and e) negative symptoms, in a sample of schizophrenic patients, and secondly to study whether these relationships persisted after stratification of the sample according to the presence or absence of SUD history. A final sample of 203 schizophrenic patients were evaluated for psychotic symptoms using the PANSS, and assessed using a neuropsychological battery to calculate a composite executive function score. Linear regression analyses were performed, with this executive score as the dependent variable, and age, duration of illness, number of psychotic episodes, positive PANSS score and negative PANSS score as independent variables. For the total sample, the regression model showed three variables to be significant predictors of the executive score: age (p=0.004), number of episodes (p=0.027), and PANSS negative score (p=0.003). However, once the sample was stratified, the regression model showed age (p=0.011) and number of episodes (p=0.011) to be predictor variables for the executive score in the group of schizophrenic patients with SUD history, while age (p=0.028) and PANSS negative score (p=0.006) were predictors in the group of schizophrenic patients without such history. These findings highlight the importance of considering SUD history in studies of cognitive function in schizophrenia. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19854622     DOI: 10.1016/j.schres.2009.09.025

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  7 in total

1.  Behavioral predictors of alcohol drinking in a neurodevelopmental rat model of schizophrenia and co-occurring alcohol use disorder.

Authors:  Jibran Y Khokhar; Travis P Todd
Journal:  Schizophr Res       Date:  2017-03-09       Impact factor: 4.939

Review 2.  The central executive network and executive function in healthy and persons with schizophrenia groups: a meta-analysis of structural and functional MRI.

Authors:  Malvina O Pietrzykowski; Katrina M Daigle; Abigail B Waters; Lance P Swenson; David A Gansler
Journal:  Brain Imaging Behav       Date:  2021-11-13       Impact factor: 3.978

3.  Different vulnerability indicators for psychosis and their neuropsychological characteristics in the Northern Finland 1986 Birth Cohort.

Authors:  Sari Mukkala; Tuula Ilonen; Tanja Nordström; Jouko Miettunen; Jukka Loukkola; Jennifer H Barnett; Graham K Murray; Erika Jääskeläinen; Pirjo Mäki; Anja Taanila; Irma Moilanen; Peter B Jones; Markus Heinimaa; Juha Veijola
Journal:  J Clin Exp Neuropsychol       Date:  2011-04       Impact factor: 2.475

4.  Microstructural abnormalities in callosal fibers and their relationship with cognitive function in schizophrenia: A tract-specific analysis study.

Authors:  Yuji Ohoshi; Shun Takahashi; Shinichi Yamada; Takuya Ishida; Kumi Tsuda; Tomikimi Tsuji; Masaki Terada; Kazuhiro Shinosaki; Satoshi Ukai
Journal:  Brain Behav       Date:  2019-07-08       Impact factor: 2.708

5.  An FMRI study of the influence of a history of substance abuse on working memory-related brain activation in schizophrenia.

Authors:  Jessica A Wojtalik; Deanna M Barch
Journal:  Front Psychiatry       Date:  2014-01-21       Impact factor: 4.157

Review 6.  Unraveling Executive Functioning in Dual Diagnosis.

Authors:  Judith C L M Duijkers; Constance Th W M Vissers; Jos I M Egger
Journal:  Front Psychol       Date:  2016-06-28

Review 7.  A Comparison of Methamphetamine-Induced Psychosis and Schizophrenia: A Review of Positive, Negative, and Cognitive Symptomatology.

Authors:  Travis A Wearne; Jennifer L Cornish
Journal:  Front Psychiatry       Date:  2018-10-10       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.